Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 12/20 | 1.00 |
| ▸ | PTPN2 | P17706 | 4/20 | 1.00 |
| ▸ | F3 | P13726 | 4/20 | 1.00 |
| ▸ | POLB | P06746 | 3/20 | 1.00 |
| ▸ | USP7 | Q93009 | 3/20 | 1.00 |
| ▸ | AKR1B10 | O60218 | 3/20 | 1.00 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 1.00 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 1.00 |
| ▸ | PSMA7 | O14818 | 2/20 | 1.00 |
| ▸ | PLA2G1B | P04054 | 2/20 | 1.00 |
| ▸ | PTPRC | P08575 | 2/20 | 1.00 |
| ▸ | PTPRF | P10586 | 2/20 | 1.00 |
| ▸ | PSMB1 | P20618 | 2/20 | 1.00 |
| ▸ | CES1 | P23141 | 2/20 | 1.00 |
| ▸ | ACP1 | P24666 | 2/20 | 1.00 |
| ▸ | PSMA1 | P25786 | 2/20 | 1.00 |
| ▸ | PSMA2 | P25787 | 2/20 | 1.00 |
| ▸ | PSMA3 | P25788 | 2/20 | 1.00 |
| ▸ | PSMA4 | P25789 | 2/20 | 1.00 |
| ▸ | PSMB8 | P28062 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oleanolic_Acid SCHEMBL71070 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL15382987 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL16126185 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL13455967 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL18688362 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL24916648 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL21892159 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL22009261 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL20904290 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 | |
| Oleanolic_Acid SCHEMBL16999276 | 1.00 | PTPN1 (1.00) | PTPN1PTPN2F3POLBUSP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12041907-B2 | Cellulose-synthase-like enzymes and uses thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-07-23 | — | — | US | disclosed |
| US-12041907-B2 | Cellulose-synthase-like enzymes and uses thereof | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-07-23 | — | — | US | disclosed |
| WO-2023151292-A1 | 3α-OLEANOLIC ACID DERIVATIVES AS HYALURONIDASE INHIBITORS AND USES THEREOF IN COSMETIC PRODUCTS | 北京青颜博识健康管理有限公司 | 2023-08-17 | — | — | WO | disclosed |
| US-20220217934-A1 | CELLULOSE-SYNTHASE-LIKE ENZYMES AND USES THEREOF | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-07-14 | — | — | US | disclosed |
| US-20180105533-A1 | BILE ACID RECEPTOR MODULATORS AND METHODS OF USE THEREOF | CITY OF HOPE | 2018-04-19 | — | — | US | disclosed |
| EP-2260851-B1 | OLEANOLIC ACID FOR THE TREATMENT OF MULTIPLE SCLEROSIS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2016-04-13 | — | — | EP | disclosed |
| US-20160009752-A1 | PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-01-14 | — | — | US | disclosed |
| US-20160009752-A1 | PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-01-14 | — | — | US | disclosed |
| US-20150191484-A1 | NOVEL COMPOUNDS HAVING A TETRACYCLIC IRIDOID SKELTON AND AN ANTI-TRYPANOSOMAL AGENT COMPRISING THE SAME AS AN ACTIVE INGREDIENT | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) | 2015-07-09 | — | — | US | disclosed |
| EP-2712863-B1 | Novel inhibitors of bacterial biofilms and related methods | SEQUOIA SCIENCES INC (US) | 2014-10-22 | — | — | EP | disclosed |
| US-7612045-B2 | Compounds, compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. (US) | 2009-11-03 | — | — | US | disclosed |
| US-20090192327-A1 | METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS | SEQUOIA SCIENCES, INC. (US) | 2009-07-30 | — | — | US | disclosed |
| US-20090192327-A1 | METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS | SEQUOIA SCIENCES, INC. (US) | 2009-07-30 | — | — | US | disclosed |
| WO-2009081211-A2 | COMPOSITION AND METHOD | BANGOR UNIVERSITY (GB) | 2009-07-02 | — | — | WO | disclosed |
| US-20080269509-A1 | Oxidation of Alcohol with Use of Hydrogen Peroxide and Tungsten Catalyst | SHIONOGI & CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080269509-A1 | Oxidation of Alcohol with Use of Hydrogen Peroxide and Tungsten Catalyst | SHIONOGI & CO., LTD. (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080145322-A1 | Componds, Composition and Method for Controlling Biofolms and Bacterail Infections | SEQUOIA SCIENCES, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080145322-A1 | Componds, Composition and Method for Controlling Biofolms and Bacterail Infections | SEQUOIA SCIENCES, INC. | 2008-06-19 | — | — | US | disclosed |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. | 2007-01-18 | — | — | US | disclosed |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | SEQUOIA SCIENCES, INC. | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080269509-A1 | Oxidation of Alcohol with Use of Hydrogen Peroxide and Tungsten Catalyst | ADH1A, ADH1C, ADH5 | PTPN1 4074/4885PTPN2 3819/4885F3 1107/4885 |
| US-20150191484-A1 | NOVEL COMPOUNDS HAVING A TETRACYCLIC IRIDOID SKELTON AND AN ANTI-TRYPANOSOMAL AGENT COMPRISING THE SAME AS AN ACTIVE INGREDIENT | TK2, TBCD, TXNRD2 | PTPN1 4049/4885PTPN2 3432/4885F3 3697/4885 |
| US-20080145322-A1 | Componds, Composition and Method for Controlling Biofolms and Bacterail Infections | CFD, SBDS, F2 | PTPN1 2771/4885PTPN2 3067/4885F3 42/4885 |
| US-20160009752-A1 | PREGNANE-OXIMINO-AMINOALKYLETHERS AND PROCESS FOR PREPARATION THEREOF, USEFUL AS ANTIDIABETIC AND ANTIDYSLIPIDEMIC AGENTS | CYP3A43, CYP11B1, CYP11B2 | PTPN1 1214/4885PTPN2 1013/4885F3 3563/4885 |
| US-20090192327-A1 | METHODS AND COMPOSITIONS FOR INHIBITING BIOFILMS | MMP9, TIMP3, MMP8 | PTPN1 1009/4885PTPN2 1209/4885F3 147/4885 |
| US-20180105533-A1 | BILE ACID RECEPTOR MODULATORS AND METHODS OF USE THEREOF | NR1H4, GPBAR1, SLC10A2 | PTPN1 1461/4885PTPN2 1341/4885F3 4859/4885 |
| US-20070014739-A1 | Compositions and methods for controlling biofilms and bacterial infections | RHOA, ALOX5, BLVRB | PTPN1 1158/4885PTPN2 1629/4885F3 91/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.